Accelerator alumnus PocDoc secures CE mark for its AI driven digital reader of lateral flow tests

Last month, PocDoc, an alumnus of the DigitalHealth.London Accelerator, secured a CE mark for its AI driven digital reader of lateral flow tests. The innovative cloud-based system allows any smartphone or tablet to become a universal digital reader of lateral flow tests and has been recorded as having over 98% accuracy.

The Covid-19 pandemic highlighted the value of using lateral flow testing at scale. PocDoc’s platform is a cost-effective solution to digitise and verify test results, store data and integrate it back into healthcare systems with full end-to-end traceability, so it can be analysed and acted upon in real-time.

PocDoc’s platform and accompanying smartphone app will allow any healthcare organisation to roll out lateral flow testing for any disease or marker at scale. This technology has huge applications in the developing world where the nearest pathology lab could be thousands of miles away from localised disease outbreaks.

Developed out of its existing smartphone blood testing platform, this technology has already been trialled on Covid-19 tests throughout the pandemic, and is now part of a major polio eradication programme with the global NGO PATH which will be deployed in polio-outbreak risk areas in the coming months. This announcement underlines PocDoc’s ongoing mission to deliver accessible and affordable diagnostics for major diseases across the globe.

Steve Roest, PocDoc CEO & Co-Founder says: “We are delighted to receive a CE mark for our AI driven digital reader platform. We developed this device with huge and unwavering support from the team at DigitalHealth.London and their positivity fueled our belief to bring this device to market. We truly believe that the answer to many global diseases is to make diagnostics more accessible and affordable by combining lateral flow tests with the PocDoc platform and app. This allows healthcare organisations to scale diagnostic testing at a fraction of the price of laboratory testing in areas that may be thousands of miles from the nearest testing lab.’’

PocDoc is an alumnus of the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator is a collaborative programme funded by London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network, MedCity, CW+ and receives match funding from the European Regional Development Fund.